QA: Anixa Biosciences Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000715446_2020_Anixa_Biosciences_Inc.pdf

Logs

Graph

Absolute values for 0000715446, Anixa Biosciences Inc

  xvar xval
0 AssetsCurrent 6,093,124
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 200,569
3 remainder_Assets 0
4 LiabilitiesCurrent 1,481,315
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,931,983
9 ResearchAndDevelopmentExpense 5,516,645
10 remainder_Expenses 1,015,968
11 remainder_Revenues 189,417
12 remainder_NetIncome 62,612
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 6,293,693
1 Liabilities 1,481,315
2 Expenses 12,464,596
3 Revenues 189,417
4 StockholdersEquity 4,812,378
5 NetIncome -12,212,567
6 ComprehensiveNetIncome -12,212,567
7 BaseVar 10,245,816
8 EconomicCapitalRatiobeforeLimitedLiability -0.443
9 EconomicCapitalRatio 1.39

Edgar->Model Mapping

Feature Distribution

Change over Time